MicroRNA‐101 suppresses liver fibrosis by targeting the TGF β signalling pathway
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Transforming growth factor‐β (TGF β) is crucial for liver fibrogenesis and the blunting of TGF β signalling in hepatic stellate cells (HSCs) or hepatocytes can effectively inhibit liver fibrosis. microRNAs (miRNAs) have emerged as key regulators in modulating TGF β signalling and liver fibrogenesis. However, the regulation of TGF β receptor I (TβRI) production by miRNA remains poorly understood. Here we demonstrate that the miR‐101 family members act as suppressors of TGFβ signalling by targeting TβRI and its transcriptional activator Kruppel‐like factor 6 (KLF6) during liver fibrogenesis. Using a mouse model of carbon tetrachloride (CCl 4)‐induced liver fibrosis, we conducted a time‐course experiment and observed significant down‐regulation of miR‐101 in the fibrotic liver as well as in the activated HSCs and injured hepatocytes in the process of liver fibrosis. Meanwhile, up‐regulation of TβRI/KLF6 was observed in the fibrotic liver. Subsequent investigations validated that TβRI and KLF6 were direct targets of miR‐101. Lentivirus‐mediated ectopic expression of miR‐101 in liver greatly reduced CCl 4‐induced liver fibrosis, whereas intravenous administration of antisense miR‐101 oligonucleotides aggravated hepatic fibrogenesis. Mechanistic studies revealed that miR‐101 inhibited profibrogenic TGFβ signalling by suppressing TβRI expression in both HSCs and hepatocytes. Additionally, miR‐101 promoted the reversal of activated HSCs to a quiescent state, as indicated by suppression of proliferation and migration, loss of activation markers and gain of quiescent HSC‐specific markers. In hepatocytes, miR‐101 attenuated profibrogenic TGFβ signalling and suppressed the consequent up‐regulation of profibrogenic cytokines, as well as TGFβ‐induced hepatocyte apoptosis and the inhibition of cell proliferation. The pleiotropic roles of miR‐101 in hepatic fibrogenesis suggest that it could be a potential therapeutic target for liver fibrosis. Copyright © 2014 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
Silencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949 · cited 1×
“Inhibition of miR-101 in vivo aggravated hepatic fibrosis Inhibition of miRNAs with modified antisense oligoribonucleotides has been shown to be an efficient and specific approach to silence endogenous miRNAs in multiple tissues [32,33].”
BackgroundHepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842 · cited 1×
“Once activated, HSCs become proliferative, pro-inflammatory and profibrogenic through increased responsiveness to soluble mediators [3,4].”
BackgroundMicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
Thum, T., Gross, C., Fiedler, J., Fischer, T., Kissler, S., Bussen, M., Galuppo, P., Just, S., Rottbauer, W., Frantz, S., et al. (2008) · Nature · doi:10.1038/nature07511 · Cited by 2,349 · cited 1×
“Inhibition of miR-101 in vivo aggravated hepatic fibrosis Inhibition of miRNAs with modified antisense oligoribonucleotides has been shown to be an efficient and specific approach to silence endogenous miRNAs in multiple tissues [32,33].”
BackgroundMyofibroblasts revert to an inactive phenotype during regression of liver fibrosis
Kisseleva, T., Cong, M., Paik, Y., Scholten, D., Jiang, C., Benner, C., Iwaisako, K., Moore-Morris, T., Scott, B., Tsukamoto, H., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201840109 · Cited by 805
Deactivation of Hepatic Stellate Cells During Liver Fibrosis Resolution in Mice
Troeger, J. S., Mederacke, I., Gwak, G., Dapito, D. H., Mu, X., Hsu, C. C., Pradere, J., Friedman, R. A., & Schwabe, R. F. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.036 · Cited by 515 · cited 1×
“miR-101 promotes HSC deactivation The reversal of activated HSCs to a quiescent state constitutes an important mechanism of liver fibrosis resolution [34,35].”
BackgroundYang, L., Roh, Y. S., Song, J., Zhang, B., Liu, C., Loomba, R., & Seki, E. (2014) · Hepatology · doi:10.1002/hep.26698 · Cited by 275 · cited 4×
“Using hepatocyte-specific TβRII-deficient mice, Yang et al [15] demonstrated that TGFβ signalling in hepatocytes promoted hepatocyte damage, profibrogenic and inflammatory cytokine production, HSC activation and fibrosis.”
BackgroundMethodInfluential
Cited by
TGF-β: the master regulator of fibrosis
Meng, X.-M., Nikolic-Paterson, D. J., & Lan, H. Y. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.48 · Cited by 3,528
Hyun, J., Wang, S., Kim, J., Rao, K. M., Park, S. Y., Chung, I., Ha, C.-S., Kim, S.-W., Yun, Y. H., & Jung, Y. (2016) · Nature Communications · doi:10.1038/ncomms10993 · Cited by 219
Sphingosine kinase 1 promotes liver fibrosis by preventing miR‐19b‐3p‐mediated inhibition of CCR2
Lan, T., Li, C., Yang, G., Sun, Y., Zhuang, L., Ou, Y., Li, H., Wang, G., Kisseleva, T., Brenner, D., et al. (2018) · Hepatology · doi:10.1002/hep.29885 · Cited by 153
“Recent studies reported that manipulating the expression of dysregulated miRNAs showed an antifibrotic effect in mouse model of CCl4-induced liver fibrosis.((35,36)) Our current study also demonstrated that upregulation of miR-19b-3p by SphK1 deficiency attenuated CCl4-induced liver fibrosis.”
BackgroundKnockdown of miR-23, miR-27, and miR-24 alters fetal liver development and blocks fibrosis in mice
Rogler, C. E., Matarlo, J. S., Kosmyna, B., Fulop, D., & Rogler, L. E. (2017) · Gene Expression · doi:10.3727/105221616x693891 · Cited by 23
Identification lncRNA LOC102551149/miR‐23a‐5p pathway in hepatic fibrosis
Dong, Z., Li, S., Si, L., Ma, R., Bao, L., & Bo, A. (2020) · European Journal of Clinical Investigation · doi:10.1111/eci.13243 · Cited by 18
Metadata
- Authors
- Tu, X., Zhang, H., Zhang, J., Zhao, S., Zheng, X., Zhang, Z., Zhu, J., Chen, J., Dong, L., Zang, Y., & Zhang, J.
- Venue
- The Journal of Pathology
- Publisher
- Wiley
- Published
- 2014-06-17
- Volume
- 234
- Issue
- 1
- Pages
- 46-59
- ISSN
- 0022-3417 (ISSN-L)
- 1096-9896
- OpenAlex
- W2119885610
- Cited by
- 125
- References
- 7
- FWCI
- 9.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.